[Treatment of small-cell lung cancer].
Treatment of small cell lung cancer (SCLC) is based on the stage of disease. While combination of chemo- and radiotherapy preferably as concomitant chemoradiotherapy represents standard treatment in patients with locally advanced tumors (UICC stage I-III), patients with metastatic disease (stage IV) should be treated with an established platinum based chemotherapy regimen. After chemotherapy and in case of an achieved tumor response treatment should be completed by an adjuvant radiation of the brain in patients with adequate performance status. In patients with a very early stage of disease without involvement of lymph node metastasis a surgical approach in combination with an adjuvant chemotherapy can be discussed. In patients with relapsed tumors second line therapies like the topoisomerase I inhibitor Topotecan have proven efficacy. Up to now neither molecular targeted therapies nor cytotoxic or immunological maintenance strategies have provided any benefit to patients with SCLC.
Krankenhaus Grosshansdorf, Zentrum für Pneumologie und Thoraxchirurgie, Grosshansdorf, Deutschland. dr.martin.reck@web.de
M
M
Reck
S
S
Bohnet
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D020266:Radiotherapy, Conformal / Q000379:methods*; D055752:Small Cell Lung Carcinoma / Q000628:therapy*
D000970:Antineoplastic Agents
N Engl J Med. 2007 Aug 16;357(7):664-72
17699816
Lung Cancer. 2003 Jan;39(1):63-9
12499096
J Clin Oncol. 2008 Sep 10;26(26):4261-7
18779613
J Clin Oncol. 1992 Feb;10(2):282-91
1310103
J Clin Oncol. 2004 Dec 1;22(23):4837-45
15570087
J Thorac Cardiovasc Surg. 2005 May;129(5):977-83
15867769
N Engl J Med. 2002 Jan 10;346(2):85-91
11784874
J Clin Oncol. 2006 Aug 20;24(24):3823-30
16921033
J Clin Oncol. 2001 Mar 15;19(6):1743-9
11251005
Lung Cancer. 2004 Jul;45(1):105-17
15196740
Ann Oncol. 2001 Apr;12(4):463-70
11398877
J Clin Oncol. 2006 Dec 1;24(34):5441-7
17135646
Eur J Cancer Clin Oncol. 1987 Nov;23(11):1697-9
2828074
N Engl J Med. 1999 Jan 28;340(4):265-71
9920950
J Natl Cancer Inst. 2003 Aug 6;95(15):1118-27
12902441
J Clin Oncol. 2009 Oct 1;27(28):4787-92
19720897
J Clin Oncol. 2006 Oct 20;24(30):4840-7
17050869
Eur J Cancer. 1999 Oct;35(10):1477-516
10673980
BMC Cancer. 2001;1:5
11432756
J Clin Oncol. 2008 Nov 20;26(33):5401-6
18854562
J Clin Oncol. 2006 May 1;24(13):2038-43
16648503
J Clin Oncol. 1999 Feb;17(2):658-67
10080612
J Clin Oncol. 1997 May;15(5):2090-6
9164222
J Clin Oncol. 2005 Jun 1;23(16):3752-9
15923572
Ann Oncol. 2000 Feb;11(2):201-6
10761756